Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,775.00
-130.00 (-4.48%)
Oct 12, 2026, 3:30 PM KST
Genexine Market Cap
Genexine has a market cap or net worth of 126.21 billion as of October 12, 2026. It is the 25,743rd most valuable company in the world and the 1,155th biggest in South Korea. Its market cap has decreased by 54.95% in one year.
Market Cap
126.21B
Enterprise Value
n/a
Revenue
5.81B
Global Rank
Country Rank
#1,155 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 126.21B, an increase of 15.76%. That is a compound annual growth rate of 0.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 126.21B | -40.77% |
| Dec 30, 2025 | 213.07B | -12.27% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Genome | 233.43B |
| GC Cell | 219.40B |
| Bioneer | 218.36B |
| Helixmith | 208.59B |
| NeoImmuneTech | 187.06B |
| Anterogen.Co.,Ltd. | 162.00B |
| MedPacto | 102.31B |
| Vaxcell-Bio Therapeutics | 101.05B |